@foxnews: NEW: Ozempic and Wegovy are facing new FDA warning labels over a rare eye condition linked to sudden, potentially permanent vision loss. After reviewing 126 clinical trials involving more than 134,000 patients, the FDA found a roughly 68% higher rate of the condition among GLP-1 users, though the agency cautions that the findings do not prove the medications cause it. The condition can cause sudden, painless vision loss, often in one eye, and has no proven treatment to reverse the damage. Download the Fox News app or go to Foxnews.com for more.

Fox News

Open In TikTok:

Region: US

Tuesday 10 November 2026 22:45:00 GMT